Estrogens, Conjugated Synthetic B Patent Expiration
Estrogens, Conjugated Synthetic B is Used for managing symptoms of menopause, including vaginal dryness, pain during intercourse, and vasomotor symptoms. It was first introduced by Aspen Pharma Usa Inc
Estrogens, Conjugated Synthetic B Patents
Given below is the list of patents protecting Estrogens, Conjugated Synthetic B, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Enjuvia | US6660726 | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
Mar 08, 2021
(Expired) | Aspen |
| Enjuvia | US6855703 | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
Feb 12, 2021
(Expired) | Aspen |
Estrogens, Conjugated Synthetic B's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List